Overview

A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery

Status:
Terminated
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate morphine intake in the first 4 hours after abdominal surgery. Morphine intake is compared between patients on placebo and patients on parecoxib/valdecoxib.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Parecoxib
Valdecoxib